Adempas Tablets and Emtricitabine and Tenofovir Disoproxil Fumarate
Determining the interaction of Adempas Tablets and Emtricitabine and Tenofovir Disoproxil Fumarate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: riociguat
Brand name: Adempas
Synonyms: Riociguat
Generic Name: emtricitabine / tenofovir
Brand name: AccessPak for HIV PEP Basic, Descovy, Truvada
Synonyms: Emtricitabine and tenofovir
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Adempas Tablets-Emtricitabine and Tenofovir Tablets
- Adempas Tablets-Emtricitabine Capsules
- Adempas Tablets-Emtricitabine Solution
- Adempas Tablets-Emtricitabine, lopinavir, ritonavir, and tenofovir
- Adempas Tablets-Emtricitabine, nelfinavir, and tenofovir
- Adempas Tablets-Emtricitabine, rilpivirine, and tenofovir
- Emtricitabine and Tenofovir Disoproxil Fumarate-Adenocard
- Emtricitabine and Tenofovir Disoproxil Fumarate-Adenoscan
- Emtricitabine and Tenofovir Disoproxil Fumarate-Adenosine
- Emtricitabine and Tenofovir Disoproxil Fumarate-Adenosine Intravenous
- Emtricitabine and Tenofovir Disoproxil Fumarate-Adenovirus Type 4 and Type 7 Vaccine Live Oral
- Emtricitabine and Tenofovir Disoproxil Fumarate-Adenovirus Vaccine